Biotechnology

  • Putteman family: From Belchim to a 57 million euro fortune in the crop protection industry

    Founded in 1987 by Dirk Putteman, Belchim Crop Protection has become a major player in the distribution of crop protection products in Europe. Despite financial challenges and the loss of its founder, the company continues to prosper thanks to strategic partnerships and a strong international presence. The Putteman family, with an estimated fortune of over 57 million euros, embodies innovation and resilience in the agricultural sector. Discover how their heritage and strategy have shaped a world-renowned company.

  • De Raedt-Verheyden family: Colossal 1.7-billion-euro empire in biotechnology

    Gino De Raedt and Frederica Verheyden have built a financial empire estimated at over 1.7 billion euros, from a simple medical laboratory in 1978 to major players in European biotechnology. Their journey, marked by strategic acquisitions and a spectacular merger with Biogroup, illustrates an exceptional entrepreneurial vision. With record dividends and diversified investments in real estate and private equity, the De Raedt-Verheyden couple have become one of Belgium's largest fortunes, while preparing for the future with their daughter Ann. Their story embodies the perfect blend of scientific innovation and financial genius.

  • 151 Million : Patrick Solvay's Colossal Legacy - From Chemicals to Golf

    Immerse yourself in the world of Patrick Solvay, heir to a chemical and financial empire valued at 151 million euros. From major influence in the global chemical industry to ownership of a prestigious golf course, discover how this great-grandson of Alfred Solvay perpetuates and diversifies the legacy of one of Belgium's most influential families.

  • Serge Goblet: The Visionary Empire of 159 Million Euros, from Commerce to Revolutionary Biotechnology

    Serge Goblet, a Belgian investor with an estimated fortune of 159 million euros, has built a diversified empire combining commerce, real estate and biotechnology. His flagship investment, Celyad Oncology SA, develops innovative CAR-T cancer therapies. Goblet illustrates the successful alliance between entrepreneurial spirit and medical innovation, contributing to therapeutic advances while consolidating a portfolio of international assets in various sectors.

  • The Van Malderen Dynasty: From Ontex to a €950 million Industrial Empire

    The Van Malderen family has built an industrial empire worth an estimated 950 million euros, from a modest production facility for medical products in Buggenhout. From Paul Van Malderen's creation of Ontex to Bart's international expansion of Drylock, via investments in real estate and winegrowing, the Van Malderens have boldly diversified their activities.

  • Jos Sluys: From Engineering to Venture Capital Empire, €450m Success Story

    Immerse yourself in the world of Jos Sluys, civil engineer turned venture capital magnate, whose fortune exceeds 450 million euros. After graduating from the University of Brussels in 1986, his career evolved from a role at Unilever to the founding of Arinso, a pioneering SAP solutions company, which enjoyed a meteoric rise until its acquisition for 375 million euros.